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reduce lipid and glycemic profiles in hypertensive patients who were seeing primary health
care providers in a low-income region of Brazil. A randomized study of 206 individuals were
followed up for the duration of 6 months. The experimental group received orientation and
planned monthly menus from the BRADA diet. In the control group, counseling was based
on standard care andmainly focused on salt intake reduction. Differences in all biochemical
parameters were compared at the baseline and at the 6-month follow-up period. The mean
age was 60.1 (±12.9) years old, and 156 subjects (119 females) completed the study. An
intention-to-treat analysis showed that both groups reduced fasting plasma glucose,
glycated hemoglobin, total cholesterol, and low-density lipoprotein cholesterol
concentrations; however, statistically significant between-group differences were found
for these parameters. The mean difference in fasting glucose was −7.0 (P < .01), −0.2 for
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683N U T R I T I O N R E S E A R C H 3 4 ( 2 0 1 4 ) 6 8 2 – 6 8 7compared with the control group. This study showed the efficacy of the BRADA diet to treat
hypertension on biochemical parameters tested in a primary health care service setting.
© 2014 Elsevier Inc. All rights reserved.1. Introduction
Systemic arterial hypertension is the most common chronic
disease [1] and is a major risk factor for cardiovascular disease
(CVD) [2] that has reached epidemic proportions [3].
The main goal of treatment for hypertension is to control
blood pressure (BP) to reduce cardiovascular morbidity and
mortality [4,5]. This effect is achieved by combining antihy-
pertensive medication with nonpharmaceutical lifestyle
changes, such [6] as weight loss, reduced sodium intake,
increased physical activity, limited alcohol consumption, and
healthy diet [7]. Nevertheless, hypertensive patients often
present with unfavorable glycemic and lipid profiles com-
pared with the general population [8].
The Dietary Approaches to Stop Hypertension (DASH)
dietary pattern combined with a reduction of salt intake and
intake of low glycemic index (GI) foods has been shown to
have beneficial effects on BP reduction [9]. In addition, studies
have shown that this dietary approach is associated with a
decrease in other CVD risk factors [10,11].
Consumption of foods with low GI values improves blood
lipid levels with a reduction in total cholesterol (TC), low-
density lipoprotein cholesterol (LDL-c) [12], triglycerides (TGs),
and fasting glucose [12-14]. However, some clinical trials have
shown inconsistent associations [15-17] or have suggested that
there is insufficient evidence to give a recommendation [18].
In this study, we evaluated the impact of how the Brazilian
Dietary Approach to Break Hypertension (BRADA) based on
DASH diet but with low sodium and low GI foods could reduce
lipid and glycemic profiles in hypertensive patients who were
seeing primary health care providers in a low-income region
of Brazil.2. Methods and materials
2.1. Design
In the present study, we conducted a 6-month randomized
controlled trial in 2 primary health care units that assist
hypertensivepatients (ProgramHiperDiaof theBrazilianMinistry
of Health), situated in the city of São Luís, Maranhão, Brazil.
2.2. Participants
From January 2010 to September 2011, all patients aged 20
years old and above who were participants of the Program
HiperDia were recruited for the study. Pregnant women,
diabetics, patients diagnosed with renal problems, and
individuals with chronic diseases such as malignancy and
acquired immunodeficiency syndrome were excluded. Of the
673 participants in the program, 206 were randomized into
either the control group (CG) (n = 101) or the experimental
group (EG) (n = 105). The randomization list was computergenerated by blocking from 2 to 10. Sealed brown envelopes
were used at the health care center to randomize the patient
selection. The evolution of the patients during the study is
shown in the Figure.
Based on the sample size, calculations assuming a reduction
in systolic blood pressure (SBP) of 7.1 mm Hg (±10 mm Hg) [20]
with a 5% significance level and 80% power, a sample size of 31
subjects per study arm (n = 62 total) was required. However, the
team opted to include all eligible hypertensive patients due to
the large losses observed in previous longitudinal experimental
studies and studies conducted at primary care units.
The definition of arterial hypertension adopted by the
HiperDia program includes values of SBP at least 140 mm Hg
and/or diastolic blood pressure at least 90 mm Hg, as
measured at a doctor’s office [7], in individuals who are not
using antihypertensive medication [21].
All patients with hypertension received monthly hyper-
tension medication free of charge. The drugs available were
angiotensin-converting enzyme inhibitors, β-blockers, and
diuretic hydrochlorotiazide, provided by the BrazilianMinistry
of Health.
This study was conducted according to the guidelines laid
down in the Declaration of Helsinki, and all procedures
involving human subjects/patients were approved by the
Ethics Committee of the University Hospital of the Federal
University of Maranhão (protocol: 312/09), and the trial was
registered in the Brazilian Register Clinical Trials of the
Ministry of Health of Brazil (RBR8ztcv9). All participants
provided informed written consent.
2.3. Protocol of study
At the baseline, the participants completed a structured
questionnaire, which included sociodemographic data, co-
morbidities, use of medication, and lifestyle factors.
2.4. Laboratory procedures
We obtained blood samples from participants after an
overnight fast (12 hours) at the baseline and after a 6-month
follow-up. Blood parameters were analyzed at a certified
laboratory using standard methods and quality control
procedures. The plasma glucose concentration was analyzed
using an enzymatic method, and glycated hemoglobin
(HbA1c) was measured by a turbidimetric inhibition immu-
noassay method. Total cholesterol, LDL-c, high-density lipo-
protein cholesterol (HDL-c), and TG levels were assessed by
enzymatic-calorimetric methods [22].
2.5. Intervention
During the 6-month follow-up study, both groups (CG and EG)
received standard care for hypertension control. At a basic
health unit, the standard care consisted of dietary salt intake
Assessed for eligibility (n 673)
Allocated to control (n 101)
Randomization (n 206)
Whithdrawn (n 19)
Moving from the city (n 1)
Other reasons (n 9)
Not meeting inclusion criteria (n 189)
Declined to participate (n 191)
Other reasons (n 87)
Completed follow-up (n 72)
Whithdrawn (n 14)
Tired of the diet (n 3)
Death of family parents (n 2)
Moving from the neighbourhood (n 2)
Completed follow-up (n 84)
Allocated to intervention (n 105)
Figure – Illustration of participant selection (adapted from Lima et al [19]).
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care provides information on the main food with high sodium
content and counseling to avoid adding table salt to food.
Furthermore, BP and anthropometric measures were recorded
monthly, and food consumption evaluation took place in the
third month and at end of the study.
In addition to standard care, the EG also received monthly
and individualized nutritional counseling (BRADA diet) pro-
vided by a nutritionist. For any questions or doubts about
nutritional counseling, the nutritionists provided contact
details to give access to the patients when required. The
returns were marked by the research team respecting
patient’s availability. The patient were contacted a day before
any appointment to confirm or rearrange them if necessary, to
ensure the patient’s follow-up and dietary compliance.
The BRADA diet was based on DASH diet [23] with low
sodium and low GI foods [24] that are highly consumed in
Brazil. It was used to design a diet that could be affordable,
sustainable, and culturally acceptable [19]. Thus, it was
instructed to increase the consumption of fruits, vegetables,
fish, whole grains, parboiled rice, beans, and natural spices
(such as pepper, garlic, chives, green scent, and oregano) as
well as to reduce the amount of saturated fat, total fat,
cholesterol, refined grains, sodium, and sweets. The counsel-
ing was further exhibited in a diet plan with a food
equivalency list and schedules in which food groups and
servings were distributed according to and between the main
meals. This plan was reinforced in each visit, beginning with
the first appointment. These recommendations were focused
on low-to-moderate GI food (<70), with glucose reference
standard and using the listed food on the “International
Tables of Glycemic Index and Glycemic Load Values [25]”.
Food item choices were also adapted for local production
and eating habits. In short, subjects were instructed to eat 3
meals and 2 to 3 snacks per day. Food items for each one ofthese eating occasions were provided by a 7-day menu plan
and a list for substitutions. Further details on data collection,
diet composition, and nutritional counseling were previously
described [19].
2.6. Statistical analyses
All analyses were performed using the SAS software (v.9.1,
SAS Institute, Cary, NC, USA). Continuous data are expressed
as the means ± SD and were analyzed by Student t test.
Categorical data are characterized as frequencies and per-
centages andwere compared by the χ2 test or Fisher exact test,
as appropriate. The paired Student t test was used to compare
differences in all biochemical parameters at baseline and the
6-month follow-up. Mixed effects models were used as an
intention-to-treat analysis of intervention. Final models were
adjusted for age, weight, and weight change. Crude and
predicted values for each biochemical parameter (before and
after intervention) are shown.3. Results
Of the 206 randomized subjects, 156 (37 men and 119 women)
completed the study (Figure). The participants showed a
mean age of 60.1 (±12.9) years, amean bodymass index of 27.6
(±4.9) kg/m2, a mean SBP of 143.4 (±24.4) mm Hg, and a mean
diastolic blood pressure of 83.5 (±12.8) mm Hg. Baseline
characteristics of the participants according to the interven-
tionwere previously published [19]. The groupswere generally
comparable across the background variables.
Table 1 shows serum levels at baseline and after
intervention according to the group. After 6 months,
patients undergoing the dietary intervention had a
significant reduction of serum TC (−46.6 mg/dL; P < .01) and
Table 1 – Concentrations of lipids and glucose parameters at baseline and postintervention, according to intervention group
Measurement Baseline Postintervention Difference Mean difference
between group
Means ± SD Means ± SD Means ± SD P a Means P b
Fasting glucose, mg/dL −7.0 <.01
EG 99.7 ± 10.5 89.7 ± 9.4 −9.6 ± 11.2 <.01
CG 99.9 ± 12.2 96.9 ± 12.9 −2.6 ± 8.5 .01
HbA1c, % −0.2 <.01
EG 5.7 ± 0.4 5.6 ± 0.4 −0.1 ± 0.3 .01
CG 5.7 ± 0.4 5.8 ± 0.5 0.1 ± 0.3 .01
TC, mg/dL −28.6 <.01
EG 228.2 ± 48.0 178.0 ± 35.8 −46.6 ± 53.5 <.01
CG 216 ± 245.7 203.1 ± 42.5 −18.0 ± 36.6 <.01
HDL-c, mg/dL 0.0 .99
EG 49.8 ± 13.1 51.3 ± 13.4 1.7 ± 10.1 .13
CG 48.5 ± 13.1 49.2 ± 13.1 1.7 ± 8.7 .11
LDL-c, mg/dL −23.8 <.01
EG 146.8 ± 39.9 101.9 ± 37.3 −42.5 ± 48.5 <.01
CG 138.6 ± 42.6 125.9 ± 37.3 −18.7 ± 37.1 <.01
TGs, mg/dL −26.8 <.01
EG 153.2 ± 75.6 114.9 ± 38.4 −31.3 ± 61.1 <.01
CG 144.6 ± 82.1 138.2 ± 75.6 −4.5 ± 49.5 .45
Values are shown asmeans ± SD; number of participants at each group for baseline (EG = 105 and CG = 101) and for postintervention (EG = 84 and
CG =72).
a Paired t test.
b Unpaired t test.
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glucose (−9.6 mg/dL; P < .01), and HbA1c (−0.1%; P < .01).
Although CG has also demonstrated reduced serum levels of
fasting glucose, HbA1c, TC, and LDL-c after 6 months, this
reduction was lower in comparison with the EG. The mean
difference of fasting glucose was −7.0mg/dL (P < .01), −0.2% for
HbA1c (P < .01), −28.6mg/dL for TC (P < .01), and −23.8mg/dL for
LDL-c (P < .01) for the EG compared with the CG. High-density
lipoprotein cholesterol remained unchanged, whereas TGs
were significantly decreased in patients who underwent the
dietary intervention but not in the CG.
With the intention to improve analyses, we used mixed
effects models (Table 2) adjusted for age, duration of
intervention, weight, and weight change. It also showed
statistically significant results for fasting glucose, HbA1c, TC,
LDL-c, and TG.4. Discussion
Using the principles of the DASH diet with the ingestion of low
sodium and low GI foods, this study evaluated the effects of
the BRADA diet on the glycemic and lipid profiles of
hypertensive patients who were being monitored by primary
care health providers. Patients who underwent the dietary
intervention experienced a significant reduction in serum TC,
LDL-c, TG concentrations, fasting plasma glucose, and HbA1c
levels, compared with individuals who received counseling
based on standard care. Although serum HDL-c concentration
increased, statistical significance was not observed. These
findings were greater and broader than those observed in
similar studies.The original DASH study compares the effects of a
traditional American diet with one enriched by fruits and
vegetables. After an 8-week follow-up period, this dietary
pattern was shown to lower TC significantly by 13.7 mg/dL,
LDL-c by 10.7 mg/dL, and HDL-c by 3.7 mg/dL [23].
A subsequent clinical trial, the DASH-Sodium study, did
not observe a significant effect of dietary sodium reduction on
blood lipid concentrations [26]. Although there is no dose
response based on sodium intake, at each level of sodium, the
lipid levels are lower for those individuals consuming the
DASH diet compared with those consuming the average
American diet [26,27].
Nordmannet al [13] compare the effect of a low-carbohydrate
diet without energy restriction vs an energy-restricted low-fat
diet on fasting glucose and lipid values in a randomized
controlled trial lasting at least 6 months. Fasting glucose, TG,
and HDL-c values changes are more favorable in individuals
assigned to the low-carbohydrate diet, but total and LDL-c
values changedmore favorably in individuals assigned to the
low-fat diet.
In an 18-month follow-up of 810 participants from the
PREMIER clinical trial, Lin et al [12] examine the association of
GI and glycemic load with clinical CVD risk factors, including
body weight, BP, serum lipids, fasting glucose, insulin, and
homocysteine. At 6 months, the authors did not observe an
association with changes in any of the risk factors. However,
at 18 months, a significant change in GI was associated with
improvements in TC (−23.8 mg/dL; P < .05) only. Goff et al [28],
in another systematic review of randomized controlled trials,
assess the effects of low GI diets on blood lipids and conclude
that there is no consistent evidence that these diets signifi-
cantly reduce total and LDL-c without affecting the HDL-c or
Table 2 – Blood concentration at baseline and
postintervention, according to intervention group, after
adjustments
Variables Baseline Postintervention
(6 mo)
Time*
intervention P
Fasting glucose,
mg/dL
<.01
EG 99.30 89.67
CG 99.67 97.01
HbA1c, % <.01
EG 5.71 5.62
CG 5.72 5.80
TC, mg/dL <.01
EG 224.62 178.01
CG 221.42 203.25
LDL-c, mg/dL <.01
EG 144.37 101.87
CG 144.82 125.95
HDL-c, mg/dL .97
EG 49.61 51.29
CG 47.74 49.36
TGs, mg/dL <.01
EG 146.14 114.87
CG 142.43 138.02
Procmixedmodel included age, weight, weight change, time, and
time* intervention (variable that measures changes over time);
number of participants at each group for baseline (EG = 105 and
CG = 101) and for postintervention (EG = 84 and CG =72).
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needed, as this finding confirms that other components of the
study design, such as dietary fiber intake, duration of the
intervention, and magnitude of change, may be responsible
for the variability observed in the effects of the lipid changes
in the lower GI intervention group. Lukaczer et al [29] evaluate
the effect of a 12-week dietary program combining low
glycemic foods with soy protein and isoflavones vs a standard
American Heart Association Step 1 diet on the reduction in
risk factors for CVD in postmenopausal women. The authors
concluded that the group consuming the low GI foods diet
shows a greater reduction in the concentrations of TC, LDL-c,
TG, glycosylated hemoglobin, homocysteine, and BP, whereas
HDL-c was observed to increase.
In ameta-analysis of randomized controlled trials, Graudal
et al [30] compare the effect of low- vs high-dietary sodium
intake on BP and blood concentrations of lipids and concluded
that adverse effect on lipids were observed with low
sodium dietary patterns even in longer term studies. Sodium
reduction resulted in a significant increase in TC (5.76 mg/dL)
and TG (6.78 mg/dL). Although the LDL-c was increased
(2.88 mg/dL) and HDL-c reduced (0.09 mg/dL), these changes
were not statistically significant. In another meta-analysis of
healthy diet trials, Lin et al [31] observe a significant reduction
only in fasting glucose (−11.34 mg/dL) without changes in the
lipid profile.
As far as we are concerned, this was the first study
developed in Brazil testing the DASH diet adopted to regional
dietary pattern combined with a reduction of salt intake and
intake of low GI (BRADA diet). Other strengths of this study
should bementioned. Themonitoring of patients emphasized
actively promoting compliance with keeping appointmentsand rescheduling missed appointments based on conve-
nience and patient availability. In addition, the methodology
applied: a longitudinal study and also an intervention
provided by nutritionists. However, these findings are not
extended to other cultures due to the subjects enrolled in this
study weremainly composed of female and elderly patients at
primary health care facilities.
In conclusion, the findings suggest that standard dietary
treatment of hypertensive patients show often unfavorable
control of lipid profile and other cardiovascular risk factors
[5,32]. The current study provided a significant contribution to
the literature by the fact that it was the first study that used a
diet plan combining the principles of the DASH diet with low
sodium and low GI foods. Our results had a beneficial impact
on all biochemical parameters measured in this study.Acknowledgment
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